BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8229123)

  • 1. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.
    Rosen PP; Groshen S; Kinne DW; Norton L
    J Clin Oncol; 1993 Nov; 11(11):2090-100. PubMed ID: 8229123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.
    Rosen PP; Groshen S; Kinne DW
    J Clin Oncol; 1991 Sep; 9(9):1650-61. PubMed ID: 1875222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmammary malignant neoplasms in patients with stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. A long-term follow-up study.
    Rosen PP; Groshen S; Kinne DW; Hellman S
    Am J Clin Oncol; 1989 Oct; 12(5):369-74. PubMed ID: 2801596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
    Rosen PR; Groshen S; Saigo PE; Kinne DW; Hellman S
    J Clin Oncol; 1989 Mar; 7(3):355-66. PubMed ID: 2918331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
    Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
    J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
    Quiet CA; Ferguson DJ; Weichselbaum RR; Hellman S
    J Clin Oncol; 1995 May; 13(5):1144-51. PubMed ID: 7738620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
    Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
    Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
    J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies.
    Chia SK; Speers CH; Bryce CJ; Hayes MM; Olivotto IA
    J Clin Oncol; 2004 May; 22(9):1630-7. PubMed ID: 15117985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma in elderly women: pathology, prognosis, and survival.
    Schaefer G; Rosen PP; Lesser ML; Kinne DW; Beattie EJ
    Pathol Annu; 1984; 19 Pt 1():195-219. PubMed ID: 6462768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of prognostic features in infiltrating lobular carcinoma of the breast.
    Frost AR; Terahata S; Yeh IT; Siegel RS; Overmoyer B; Silverberg SG
    Mod Pathol; 1995 Oct; 8(8):830-6. PubMed ID: 8552571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time interval from breast-conserving surgery to breast irradiation in early stage node-negative breast cancer: 17-year follow-up results and patterns of recurrence.
    Vujovic O; Yu E; Cherian A; Dar AR; Stitt L; Perera F
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):319-24. PubMed ID: 25636757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years.
    Rosen PP; Groshen S
    Surg Clin North Am; 1990 Aug; 70(4):937-62. PubMed ID: 2371651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.